A new technology upgrades dedicated ICU workstations

Developed in collaboration with international clinicians, Orchestra workstations feature state-of-the-art infusion systems.

The unique Channel Relay enhances haemodynamic stability in ICU patients
The unique Channel Relay enhances haemodynamic stability in ICU patients

‘Years of clinical use have proven their unique and smart functionalities, which are continually upgraded with new technologies,’ France-based Fresenius Kabi* reports. ‘Recently, the embedded dose-error reduction software has been updated. The customisable drug library, for up to 150 drugs, ensures safe pump programming that prevents over or under dosage.’
Functions include:
• Channel Relay – this links two syringes that automatically provide an uninterrupted and constant flow rate. Blood pressure is therefore better controlled and haemodynamic stability in ICU patients is enhanced.
• The Occlusivity Check System (OCS) – to prevent any risk of free-flow, this patented auto-test checks the correct working order of the infusion pump in association with its tubing set.

20.11.2008

More on the subject:

Related articles

Photo

News • Study on vascular access options

Intraosseous or intravenous: which way to administer medication during cardiac arrest?

Research shows a one-third chance of restoring blood circulation during cardiac arrest, regardless of whether the medication is administered into the bloodstream or bone marrow.

Photo

News • Thermal-responsive magnetic nanorobot collectives

Stopping brain bleeds from aneurysms with tiny robots

Brain aneurysms cause around 500,000 deaths globally each year and can lead to stroke and disability. Now, researchers created nanoscale robots to manage bleeds in the brain caused by aneurysms. 

Photo

Article • Emergency Department

Taking extra care of pregnant women with severe hypertension

Emergency care specialists must be aware of critically-important factors when treating pregnant women with severe hypertension. At the EUSEM conference in Barcelona, Dr Timo Suonsyrjä, Chief…

Related products

Subscribe to Newsletter